CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Clinical trials for CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to control blood cancer longer
Disease control Recruiting nowThis study tests a new drug combination (DZD8586 plus other medicines) in adults with chronic lymphocytic leukemia or small lymphocytic lymphoma who have not yet been treated. The goal is to see if the combination can control the cancer for at least 2 years and to check for side …
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Dizal (Jiangsu) Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 04:23 UTC
-
New hope for blood cancer patients: experimental drug DZD8586 enters final testing phase
Disease control Recruiting nowThis study tests a new drug called DZD8586 against standard treatments in about 250 adults whose chronic lymphocytic leukemia or small lymphocytic lymphoma has come back or stopped responding to prior therapy. The goal is to see if DZD8586 can keep the cancer from growing longer …
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE3 • Sponsor: Dizal (Jiangsu) Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 04:22 UTC
-
Heart-Safe cancer treatment? new study offers hope for CLL patients
Disease control Recruiting nowThis study tests whether a drug called acalabrutinib can control chronic lymphocytic leukemia (CLL) while being safer for the heart than the current drug ibrutinib. About 61 adults with CLL who had heart side effects from ibrutinib will switch to acalabrutinib. Researchers will u…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Seema Bhat • Aim: Disease control
Last updated May 26, 2026 04:19 UTC
-
New combo aims to tackle lymphoma in communities often left behind
Disease control Recruiting nowThis early-stage trial tests two oral drugs, zanubrutinib and sonrotoclax, for people with B-cell non-Hodgkin lymphoma that has returned or not responded to prior treatment. The study focuses on Black, Hispanic, and other underrepresented groups to improve access and outcomes. Ab…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 04:14 UTC
-
New drug shows promise for Hard-to-Treat blood cancers
Disease control Recruiting nowThis study is for people with B-cell blood cancers like lymphoma and leukemia. It tests a new drug, BGB-16673, that breaks down a protein helping cancer grow. The goal is to find the right dose and see if it is safe and shrinks tumors. About 146 people in China will take part.
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: BeiGene • Aim: Disease control
Last updated May 26, 2026 03:55 UTC
-
New hope for Tough-to-Treat blood cancers: DZD8586 trial opens
Disease control Recruiting nowThis study tests a new drug, DZD8586, in about 155 adults whose chronic lymphocytic leukemia or small lymphocytic lymphoma has returned, stopped responding to prior treatment, or caused unbearable side effects. The goal is to see how well the drug shrinks tumors and what side eff…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Heart watch: tiny implant tracks dangerous rhythms in cancer patients
Knowledge-focused Recruiting nowThis study is for people starting a type of cancer drug called BTK inhibitors, which can sometimes cause irregular heartbeats. Researchers will implant a small heart monitor under the skin to watch for these heart rhythm problems. The goal is to learn how often these problems hap…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: NA • Sponsor: Northwell Health • Aim: Knowledge-focused
Last updated May 26, 2026 04:18 UTC
-
Exercise may strengthen immunity in Early-Stage blood cancer patients
Knowledge-focused Recruiting nowThis study looks at how short-term and long-term exercise affects the immune system of people with slow-growing types of non-Hodgkin lymphoma and chronic lymphocytic leukemia. Researchers want to see if a 12-week exercise program can improve immune function and possibly delay dis…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 26, 2026 04:17 UTC